Characteristics of prostatic infarcts and their effect on serum prostate-specific antigen and prostatic acid phosphatase.
OBJECTIVE
To determine how prostatic infarcts affect serum prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) levels.


METHODS
Two hundred eighteen clinically benign, whole prostates were obtained at autopsy, completely sectioned, and examined histologically. PSA and PAP levels were determined from premortem serum.


RESULTS
Six of the 218 (2.8%) prostates had infarcts. The infarcts were usually multiple and usually located in the central and/or middle concentric zones of the middle third of the prostate without a preference for a particular lobe. Serum PSA by immunoradiometric assay were elevated in all 6 cases. Serum PAP by both enzymatic assay (ACA), and immunoradiometric assay were available for 5 cases and were elevated by both methods in 2 cases, approached elevated levels by both methods in 1 case, and were normal by both methods in 2 cases. The PSA and PAP levels appeared to be affected more by the age than by the size of the infarct.


CONCLUSIONS
Prostatic infarcts elevate PSA levels more frequently than PAP levels, and prostatic infarcts may be responsible for some unexplained elevations of serum PSA and PAP levels.
Brawn
P N
PN
Department of Pathology, Veterans Affairs Medical Center, Ann Arbor, Michigan.
Foster
D M
DM
Jay
D W
DW
Kuhl
D
D
Speights
V O
VO
Johnson
E H
EH
Coffield
K S
KS
Lind
M L
ML
Karl
R
R
Weaver
B
B
D000135:Acid Phosphatase / Q000097:blood*; D000368:Aged; D006801:Humans; D007238:Infarction / Q000097:blood* / Q000209:etiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000098:blood supply*; D017430:Prostate-Specific Antigen / Q000097:blood*
D000135:Acid Phosphatase; D017430:Prostate-Specific Antigen